This is Thomas Sullivan's Typepad Profile.
Join Typepad and start following Thomas Sullivan's activity
Join Now!
Already a member? Sign In
Thomas Sullivan
Columbia, Maryland
Former political consultant who founded Rockpointe, Inc. a bio-medical education company in 1995.
Interests: marketing, politics, baseball, cycling, medicine, university of florida sports., medical education, track and cross country,driving kids to various practices
Recent Activity
Image
The longest running and most highly acclaimed transparency meeting takes place August 18-20 in Washington, DC this year. CBI's Transparency & Aggregate Spend Forum provides an amazing opportunity to hear from industry experts and interact with other compliance and agg... Continue reading
Posted yesterday at Policy and Medicine
Image
Transparency is increasingly a global phenomenon. Australia is no exception. Medicines Australia, Australia's industry body, recently revamped the disclosure provisions of its Code of Conduct, and sent the reforms to the Australian Competition and Consumer Commission (ACCC) for approval. The... Continue reading
Posted yesterday at Policy and Medicine
Image
Yesterday, several physician organizations and pharmaceutical industry trade groups petitioned CMS to provide clarity on a number of important aspects of the Physician Payments Sunshine Act. Their letter argued for proper context surrounding industry payments, increased outreach to educate physicians... Continue reading
Posted yesterday at Policy and Medicine
Image
A new report by ZS Associates looked at call reports for more than 200 pharmaceutical sales teams and found that reps’ access to physicians has declined steadily since the firm’s first report in 2008. In 2014, 49% of physicians in... Continue reading
Posted 2 days ago at Policy and Medicine
Image
Even as two Federal Appeals courts spilt on the issue of tax credits for purchasers of exchanges run by the federal government, states are getting out of the business of running exchanges. We have previously reported on the problems associated... Continue reading
Posted 5 days ago at Policy and Medicine
Image
As reported, earlier this year, the Food and Drug Administration (FDA) released the FDASIA Health IT Report (Report). This Report fulfills Section 618 of the Food and Drug Administration Safety and Innovation Act (FDASIA), Public Law 112-144, which requires that... Continue reading
Posted 6 days ago at Policy and Medicine
Image
The Accreditation Council for Continuing Medical Education (ACCME) recently published its 2013 Annual Report Data which includes data on the size and scope of the continuing medical education (CME) enterprise nationwide. The report shows that in 2013: CME Economy grew... Continue reading
Posted 6 days ago at Policy and Medicine
Image
The Dispute Resolution process of the Physician Payments Sunshine Act takes place in the time between when pharmaceutical and device manufacturers submit their payment data to the Centers for Medicare and Medicaid Services (CMS) and when the data becomes public... Continue reading
Posted 7 days ago at Policy and Medicine
Image
Healthcare leaders "don't have a choice" but to innovate, author, consultant and futurist Ian Morrison told the National Healthcare Innovation Summit. Morrison is the author of several books including, most recently, Leading Change in Healthcare: Building a Viable System for... Continue reading
Posted 7 days ago at Policy and Medicine
Image
The Chinese bribery allegations against GlaxoSmithKline (GSK) have taken a scary turn for pharmaceutical executives working abroad. According to Chinese authorities, Glaxo's employees engaged in a bribery scheme with doctors totaling $483 million. Mark Reilly, the former China head of... Continue reading
Posted Jul 22, 2014 at Policy and Medicine
Image
Today, the Centers for Medicare and Medicaid Services will host a national provider call for the dispute and review process of Open Payments (the Sunshine Act). The call will take place from 2:30-4:00 pm eastern time. Register here, and also... Continue reading
Posted Jul 22, 2014 at Policy and Medicine
Image
In releasing guidance entitled, "Balancing Premarket and Postmarket Data Collection for Devices Subject to Premarket Approval - Draft Guidance for Industry and Food and Drug Administration Staff," FDA attempts to clarify current policy on balancing premarket and postmarket data collection... Continue reading
Posted Jul 21, 2014 at Policy and Medicine
Image
Pharmaceutical and device manufacturers have been busy working through the first reporting year under the Physician Payments Sunshine Act. June 30, 2014 marked the deadline for companies to submit detailed reports to the Centers for Medicare and Medicaid Services (CMS)... Continue reading
Posted Jul 18, 2014 at Policy and Medicine
Image
On July 8, 2014, the French National Assembly voted a draft law proposal that would potentially allow healthcare professionals to prescribe off-label drugs, even if there is an approved drug available for treatment. The draft law specifically references Avastin, a... Continue reading
Posted Jul 17, 2014 at Policy and Medicine
Image
A recent study by CMEology found that continuing medical education (CME) can save significant healthcare costs. The authors used an educational activity about preventing bleeding-related complications from cardiac and thoracic surgeries for their analysis. The results suggest that even if... Continue reading
Posted Jul 17, 2014 at Policy and Medicine
Image
The Dispute Resolution period of the Physician Payments Sunshine Act has been open for two days now. Physicians are able to register in Open Payments, look through the manufacturer's transfer of value reports, and either (1) affirm their payment, (2)... Continue reading
Posted Jul 16, 2014 at Policy and Medicine
Image
Today you can view important sessions on healthcare innovation streamed live from Philadelphia as part of MedCityNews' CONVERGE Summit for Healthcare Innovation. The summit is host to many interesting sessions; the full schedule is available here. MedCity CONVERGE "provides the... Continue reading
Posted Jul 15, 2014 at Policy and Medicine
Image
The Eighth International Pharmaceutical Compliance Congress took place in Dubai, UAE earlier this year. The conference featured many useful programs and impressive speakers that highlighted how compliance is an increasingly global challenge. We recently featured coverage of India's healthcare compliance... Continue reading
Posted Jul 15, 2014 at Policy and Medicine
Image
The Affordable Care Act puts a lot of emphasis on transparency. Section 6002, the Physician Payments Sunshine Act, requires manufacturers to report to the Centers for Medicare and Medicaid Services (CMS) almost every transfer of value they make to doctors—from... Continue reading
Posted Jul 14, 2014 at Policy and Medicine
Image
The Centers for Medicare and Medicaid Services (CMS) has just announced that physicians and teaching hospitals can begin final registration and reviewing their data in the Open Payments system on Monday, July 14. Although registering with Open Payments is voluntary,... Continue reading
Posted Jul 11, 2014 at Policy and Medicine
Image
As recently noted, in 1997, pharmaceutical firms began advertising directly to consumers (DTC) via television ads, as a result of guidance from FDA that required drug advertisements to provide only a "brief summary" of side effects, rather than the full... Continue reading
Posted Jul 11, 2014 at Policy and Medicine
Image
We recently reported that Minnesota had updated its statute to require manufacturers report their payments to physician assistants, nurse practitioners, veterinarians, and dental therapists. On July 9, the Minnesota Board of Pharmacy released a memo to clarify their position on... Continue reading
Posted Jul 10, 2014 at Policy and Medicine
Image
On July 15, 2014, hear an experienced panel discuss important new developments and obligations during this crucial period of the Physician Payments Sunshine Act. Policy & Medicine readers will enjoy an ABA Health Law Section discount. Please click here to... Continue reading
Posted Jul 10, 2014 at Policy and Medicine
Image
The 21st Century Cures initiative is a new bipartisan effort to bridge the gap between medical advances and the regulatory policies that govern them. The initiative started with a collaboration between Representative Fred Upton (R–MI), the chair of the Energy... Continue reading
Posted Jul 9, 2014 at Policy and Medicine
Image
The CME Coalition has released a proposed design template for the disclosure of commercial support on CME materials. Recently, we reported that the Accreditation Council for Continuing Medical Education (ACCME) decided to adopt changes to their Standards for Commercial Support... Continue reading
Posted Jul 9, 2014 at Policy and Medicine